Boston, Oct. 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, "Anti-Parkinson's Drugs: Global Markets to 2030" is projected to grow from $6.1 billion in 2025 to $9.2 ...

An estimated 1.1 million Americans are living with Parkinson's disease (PD), making it the second most common neurodegenerative disease after Alzheimer's. "Parkinson's is a disease in which neurons ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A proposed drug pricing plan could stifle innovation for Parkinson's treatments and hurt the life sciences sector.

For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s movement signal. A wave of new research is now overturning that picture, ...

When the hospital germ Pseudomonas aeruginosa infects the body, it uses the sugar-binding protein LecA to attach itself to human cells, invade them, and form so-called biofilms. LecA thus plays a ...

Benztropine, a drug prescribed for tremors in Parkinson’s disease, has shown promise against tuberculosis (TB) in both human cell and mouse models. The corresponding study was published in npj ...

It's easy to see discarded plastic as nothing more than waste. Much of it ends up in landfill, breaking down into microplastics that seep into water supplies and threaten the environment, and ...

A study has revealed that commonly prescribed medications may increase the risk of dementia, according to scientific research. The research suggests that regular use of certain widely-prescribed drugs ...

Two drugs used to treat Parkinson's disease have been found to cause damage to heart valves, say researchers. The drugs, pergolide (Permax) and cabergolide (Dostinex or Cabaser), are in the class of ...